Results 111 to 120 of about 12,138 (221)
Presence of Anticardiolipin Antibodies in Patients with Dementia: A Systematic Review and Meta-Analysis. [PDF]
Islam MA +5 more
europepmc +1 more source
Vascular headaches and the anticardiolipin antibodies. [PDF]
Hering, R, Couturier, E G, Steiner, T J
openaire +3 more sources
Antiphospholipid Syndrome, Review of 24 Iraqi patients
Background: Antiphospholipid syndrome (APS) is a disorder in which vascular thrombosis and / or recurrent pregnancy losses occur in a patient who has laboratory evidence of antibodies against phospholipids or phospholipids binding protein cofactor ...
Ahmed Kh. Yassin, Ali M. Jawad
doaj
The objective of the study was to evaluate, in patients with unexplained infertilty, the possible relationship between anticardiolipin antibodies and indices of uterine artery Doppler measurements.
L. Sgarbi +5 more
core
The correlation of lupus anticoagulant and anticardiolipin antibodies with hematological parameters and clinical findings in sickle cell disease at steady state phase. [PDF]
Almorish MA +11 more
europepmc +1 more source
Prevalence of anticardiolipin antibodies in patients with nephrotic syndrome
Antikardiyolipin antikorlar (AKA) klinik olarak hiperkoagülabilte ile ilişkili otoantikorlardır. Nefrotik sendrombir hiperkoagülabilite durumu olarak kabul edilmektedir.
Oğuz, Yusuf +4 more
core
Even low levels of anticardiolipin antibodies are associated with pregnancy-related complications: A monocentric cohort study. [PDF]
Matraszek VV, Krofta L, Hromadnikova I.
europepmc +1 more source
Sneddon's syndrome with anticardiolipin antibodies complications and treatment
We investigated 2 patients with Sneddon's syndrome, elevated anticardiolipin antibodies and systemic complications, which included stroke, habitual abortions, cardiac valvular lesions, acrocyanosis, hypertension and renal insufficiency.
Lotz, B.P. +3 more
core
The antiphospholipid syndrome (APS) is diagnosed in patients with recurrent thromboembolic events and/or pregnancy loss in the presence of persistent laboratory evidence for antiphospholipid antibodies.
core

